Plus Therapeutics, Inc. Series F Preferred Stock SUBSCRIPTION AND INVESTMENT REPRESENTATION AGREEMENTSubscription and Investment Representation Agreement • March 3rd, 2023 • Plus Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS AGREEMENT, dated as of March 3, 2023, is by and between Plus Therapeutics, Inc., a Delaware corporation (the “Company”), and the undersigned subscriber (the “Subscriber”). In consideration of the mutual promises contained herein, and other good, valuable and adequate consideration, the parties hereto agree as follows:
